Prediction of absorbed dose by tumors and critical organs after Lu-177-DOTATATE therapy using pretherapeutic Ga-68-DOTATOC PET/CT

被引：0
|
作者：
Kim, Yong-il [1 ]
Oh, Jungsu [1 ]
Yoo, Changhoon [1 ]
Ryoo, Baek-Yeol [1 ]
Ryu, Jin-Sook [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
76
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation of the pretherapeutic Ga-68-DOTATOC tumor SUV with the subsequently absorbed dose of Lu-177-DOTA-Octreotate
    Ezziddin, Samer
    Lohmar, Jonas
    Yong-Hing, Charlotte
    Sabet, Amir
    Ahmadzadehfar, Hojjat
    Biersack, Hans Juergen
    Guhlke, Stefan
    Reichmann, Karl
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [2] Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?
    Ezziddin, Samer
    Lohmar, Jonas
    Yong-Hing, Charlotte J.
    Sabet, Amir
    Ahmadzadehfar, Hojjat
    Kukuk, Guido
    Biersack, Hans-Juergen
    Guhlke, Stefan
    Reichmann, Karl
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : E141 - E147
  • [3] Exploration of Ga-68 DOTA PET radiomics to predict the absorbed dose of Lu-177 DOTATATE® therapy of midgut neuroendocrine tumors
    Brahmi, S.
    Vallot, D.
    Vija, L.
    Dierickx, L.
    Courbon, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 176 - 176
  • [4] Predicting Tumor-Absorbed Doses of 177Lu-Octreotate Peptide Receptor Radionuclide Therapy by Pretherapeutic 68Ga-DOTATOC PET
    Ezziddin, S.
    Lohmar, J.
    Yong-Hing, C.
    Sabet, A.
    Ahmadzadehfar, H.
    Biersack, H.
    Guhlke, S.
    Reichmann, K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 198 (05)
  • [5] Peptide receptor radionuclide therapy with Y-90 DOTATOC and Lu-177 DOTATATE in patients with progressive meningioma and prognostic value of pretherapeutic Ga-68 DOTATOC/-TATE PET/CT
    Ilhan, Harun
    Seystahl, Katharina
    Veit, Stoecklein
    Schueller, Ulrich
    Rushing, Elisabeth
    Nicolas, Guillaume
    Schaefer, Niklaus
    Pangalu, Athina
    Lehner, Sebastian
    Bartenstein, Peter
    Michael, Weller
    Tonn, Joerg
    Sommerauer, Michael
    Albert, Nathalie
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Ortega, Claudia
    Wong, Rebecca K. S.
    Schaefferkoetter, Josh
    Veit-Haibach, Patrick
    Myrehaug, Sten
    Juergens, Rosalyn
    Laidley, David
    Anconina, Reut
    Liu, Amy
    Metser, Ur
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) : 1406 - 1414
  • [7] Correlation study between 68Ga-DOTATOC PET/CT metrics and 177Lu-DOTATATE dosimetry for non-pancreatic neuroendocrine tumors
    Texier, J. S.
    Jocmek, M.
    Dierickx, L.
    Vallot, D.
    Brillouet, S.
    Lamesa, C.
    Courbon, F.
    Vija, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 160 - 160
  • [8] Diagnosis of Men-I Syndrome on Ga-68-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With Lu-177-DOTATATE
    Gupta, Santosh Kumar
    Singla, Suhas
    Damle, Nishikant A.
    Agarwal, Krishankant
    Bal, Chandersekhar
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 10 (04)
  • [9] Correlation study between 68Ga-DOTATOC PET metrics and 177Lu-DOTATATE dosimetry for metastatic midgut neuroendocrine tumors
    Texier, J.
    Jocmek, M.
    Dierickx, L.
    Brillouet, S.
    Vallot, D.
    Caselles, O.
    Terroir, M.
    Cassou-Mounat, T.
    Lamesa, C.
    Maronnier, Q.
    Vija, L.
    Courbon, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S577 - S577
  • [10] The Use of 68Ga DOTATATE PET/CT for Diagnostic Assessment and Monitoring of 177Lu DOTATATE Therapy in Pituitary Carcinoma
    Novruzov, Fuad
    Aliyev, Jamil A.
    Jaunmuktane, Zane
    Bomanji, Jamshed B.
    Kayani, Irfan
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (01) : 47 - 53
12345